No Data
Henlius (02696) Hanquyoudeng makes its debut in the USA, further expanding global supply sources.
On November 29, henlius (02696) officially shipped its independently developed and produced trastuzumab biosimilar, Hanquyou (usa brand name: HERCESSI, europe brand name: Zercepac), from the company's Songjiang base (1), en route to the usa market.
Shanghai Henlius Biotech Extends Key Collaborations in China
"Love Cycling, Together We Ride" The 2024 Healthy Cycling Charity Event was successfully held.
Shanghai, November 23, 2024 /PR Newswire/ -- November is International Lung Cancer Awareness Month. To enhance the society's understanding and attention towards pulmonary diseases, the "Love Your Lungs Cycling, Accompanying You and Me" 2024 Healthy Cycling Charity Event, hosted by henlius and supported by the Shanghai Fosun Public Welfare Fund and fosun pharma, will be successfully held in Shanghai on November 23. The event invited more than a hundred people including medical staff, media personnel, cycling enthusiasts, and employee volunteers to participate in this green and healthy sport of cycling, integrate health science knowledge, collectively call on the public to pay attention to lung health, advocate healthy lifestyles, and actively promote the concept of loving and protecting the lungs.
Henlius Doses First Patient in Phase 3 Study of Combo Treatment for Gastric Cancer
Shanghai Henlius Advances Privatization Plans With Fosun
Shanghai Henlius Biotech Begins Phase 3 Trial for Cancer Therapy
No Data
No Data
